TPD52L2 and renal cell carcinoma: First, at the mRNA level, TPD52L2 expression was demonstrated to be elevated in ccRCC tissues through GSE66272, GSE53757, GSE46699, and GSE36895 microarray data of a total of 195 RCC tissues, as shown in Figures 3A–D.